Worth reading
45Recurring
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
48560
Shares (4,856 stock acquisition rights × 10 shares per right)Wording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of Series 4 Stock Compensation-Type Stock Acquisition Rights of Riso Kyoiku Co., Ltd.
発行・処分する株式数
Maximum 48,560 common shares (4,856 stock acquisition rights, 10 shares per right)
Intended allottee
Category Directors of the Company (excluding outside directors) / Number of Employees 5 / Number of stock acquisition rights 4,856
Total Stock-Based Compensation
Monetary compensation equivalent to the total payment amount for the stock acquisition rights. The amount is Not disclosed.
Terms of the stock acquisition rights
Exercise price
¥1 per share. The amendment provisions are Not disclosed
Exercise period
From 23 September 2021 to 22 September 2061
Number of Stock Acquisition Rights
Total issuance: 4,856 rights. Not disclosed for the number of rights remaining unexercised
Reason for acquisition without consideration
The Company may acquire unexercised stock acquisition rights without consideration if they become non-exercisable before exercise under the exercise conditions or the stock acquisition rights allotment agreement, or if a proposal seeking approval for a corporate reorganization is approved.
Categories and Number of Persons Covered
5 directors of the Company, excluding outside directors; 4,856 rights
Basis for determining the amount to be paid
The fair value calculated using the Black-Scholes model on the allotment date
Procedures under the Corporate Code of Conduct
The terms of the offering were determined at a Board of Directors meeting held on 24 August 2021.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of Series 4 Stock Compensation-Type Stock Acquisition Rights of Riso Kyoiku Co., Ltd. |
| Number of shares to be issued or disposed of | Maximum 48,560 common shares (4,856 stock acquisition rights, 10 shares per right) |
| Intended allottee | Category Directors of the Company (excluding outside directors) / Number of Employees 5 / Number of stock acquisition rights 4,856 |
| Basis for determining the amount to be paid | The fair value calculated using the Black-Scholes model on the allotment date |
| Exercise price | ¥1 per share. The amendment provisions are Not disclosed |
| Exercise period | From 23 September 2021 to 22 September 2061 |
| Number of Stock Acquisition Rights | Total issuance: 4,856 rights. Not disclosed for the number of rights remaining unexercised |
| Reason for acquisition without consideration | The Company may acquire unexercised stock acquisition rights without consideration if they become non-exercisable before exercise under the exercise conditions or the stock acquisition rights allotment agreement, or if a proposal seeking approval for a corporate reorganization is approved. |
| Categories and Number of Persons Covered | 5 directors of the Company, excluding outside directors; 4,856 rights |
| Total Stock-Based Compensation | Monetary compensation equivalent to the total payment amount for the stock acquisition rights. The amount is Not disclosed. |
| Procedures under the Corporate Code of Conduct | The terms of the offering were determined at a Board of Directors meeting held on 24 August 2021. |
Items this document does not state (17)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesTransfer restriction periodConditions for lifting transfer restrictionsUnderwriter / lead underwriterOverallotmentStock Split RatioMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To link directors’ compensation to business performance and the share price, and to encourage their motivation and morale to contribute to improved medium- to long-term performance and corporate value by sharing with shareholders not only the benefits of a rising share price but also the risks of a declining share price.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.